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Abstract: Evidence has emerged across the past few decades that the lifetime risk of developing 
morbidities like type 2 diabetes, obesity, and cardiovascular disease may be influenced by expo-
sures that occur in utero and in childhood. Developmental abnormalities are known to occur at 
various stages in fetal growth. Epidemiological and mechanistic studies have sought to delineate 
developmental processes and plausible risk factors influencing pregnancy outcomes and later 
health. Whether these observations reflect causal processes or are confounded by genetic and 
social factors remains unclear, although animal (and some human) studies suggest that epige-
netic programming events may be involved. Regardless of the causal basis to observations of 
early-life risk factors and later disease risk, the fact that such associations exist and that they are 
of a fairly large magnitude justifies further research around this topic. Furthermore, additional 
information is needed to substantiate public health guidelines on lifestyle behaviors during 
pregnancy to improve infant health outcomes. Indeed, lifestyle intervention clinical trials in 
pregnancy are now coming online, where materials and data are being collected that should 
facilitate understanding of the causal nature of intrauterine exposures related with gestational 
weight gain, such as elevated maternal blood glucose concentrations. In this review, we provide 
an overview of these concepts.
Keywords: early-life, epigenetic, programming, pregnancy, cardiometabolic, obesity, cardio-
vascular disease, type 2 diabetes
Background
The global obesity epidemic has occurred in the wake of major recent social, demo-
graphic, behavioral, and economic adaptations; of particular relevance are the wide-
spread adoption of sedentary behaviors, reduced physical activity, and ready access 
to energy-dense, micronutrient-deficient (eg, low iodine, iron, zinc, and vitamin A 
content) foods.
Adipocyte biogenesis and storage within adipocytes of energy-dense fatty acids 
(predominantly triglycerides) are natural processes that have enabled humans and 
other species to survive prolonged periods of food deprivation throughout evolution. 
Indeed, starvation1,2 and rare diseases associated with very low levels of adipose tissue 
(eg, partial lipodystrophies, anorexia nervosa, and cachexia) are life-threatening and 
can render affected women infertile owing to insufficient levels of hormones such as 
leptin.3,4 Hence, fat accumulation and retention are natural processes that have strong 
biologic drivers, many encoded by genes. However, energy-dense, nutrient-deficient 
foods are often easily accessible in most modern industrialized societies. Thus, an 
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set against a backdrop of genetic susceptibility to protect 
against leanness likely underlie the high rates of obesity and 
related cardiometabolic disorders seen in most developed and 
developing societies today.
Importantly, there is considerable variability in suscepti-
bility to obesity, given exposure to obesogenic environmental 
factors, with studies in twins5 and family pedigrees6 clearly 
showing that heritable factors (including genes) contribute 
to these differences (see Bar-Or et al7 for review of evidence 
in childhood). Studies designed to identify the specific loci 
responsible for modifying the effects of environmental 
exposures on obesity predisposition have been underway 
for more than 2 decades, yet very little reliable evidence 
has emerged.8 Nevertheless, there is an emerging body of 
evidence documenting the molecular changes that underlie 
these interactions, including those that focus on differences in 
gene expression and deoxyribonucleic acid (DNA) methyla-
tion (epigenetics).
Whilst many of these studies have focused on adult 
cohorts, risk trajectories for dysmetabolic outcomes, 
including obesity, type 2 diabetes (T2D), and cardiovascu-
lar disease (CVD), are thought to be shaped early in life. 
The accrual of data in recent years exploring risk factors 
arising in pregnancy and childhood provides compelling 
evidence that the risk trajectory for metabolic disease 
originates in childhood or perhaps even earlier in utero (see 
Table 1 for a summary of key studies cited in this review). 
We hypothesize that dysmetabolic programming events 
occurring within critical windows in development pre-
dispose the offspring to CVD and T2D as adults, and that 
these processes may be mediated by epigenetic processes 
that give rise to transgenerational inheritance.
Table 1 Summary of key studies and their major findings
Key studies Key findings Model
Huang et al,30 Li et al,28,102 Association between intrauterine famine exposure and cardiometabolic  
disease susceptibility
Human
Ravelli et al103 Association between exposure to prenatal nutritional stress during the  
Dutch famine, especially in late gestation, and adult glucose intolerance
Human
Dabelea et al,36 Lauren et al,41 Pettitt and Jovanovic,35 
Savona-ventura and Chircop,34 wei et al104
Association between under- and overnourished pregnancies and a higher risk  
of metabolic disease in adulthood; the relationship appears to be U-shaped
Human
Franks et al39 Much higher risk of developing diabetes among American indian offspring of  
diabetic pregnancies
Human
Bygren et al105 exposure in paternal grandmothers to drastic changes in food supply appear  
to confer transgenerational responses in the grandchildren
Human
Heijmans et al47 Association between prenatal exposure to the Dutch famine and reduced  
DNA methylation of the imprinted IGF2 gene
Human
Ng et al49 Paternal exposure to a high-fat diet is associated with altered expression  
of pancreatic islet genes and β-cell dysfunction in female offspring, despite  
normal adiposity
Animal
Poulsen et al106 Association between low birth weight and later noninsulin-dependent  
diabetes in monozygotic twins is only partly due to genotype and may  
be largely explained by the intrauterine environment
Human
Sullivan et al54 Diabetes-associated GRS predicts GDM in women from the Diabetes  
Prevention Program but not progression to diabetes
Human
Andersson et al,107 Freathy et al,57 Zhao et al108 Association between type 2 diabetes risk alleles and fetal growth and birth  
weight in individuals from the Danish inter99 study
Human
Dina et al,64 Horikoshi et al,109 Frayling et al110 Genetic links between fetal and early childhood growth and adult obesity  
and metabolism
Human
Cecil et al,66 Church et al,68  
Tung et al,69 wardle et al71
FTO plays a role in appetite regulation and energy balance Human and 
animal
Sovio et al111 Association between FTO variant and growth and development in infancy  
and late childhood
Human
whitaker et al,112 williams and Goulding74 Association between early adiposity rebound and later adiposity Human
eriksson et al88 Association between catch-up growth during childhood and death from  
coronary heart disease
Human
Barker et al,83 Calderon et al,82 Lappas et al113 Placenta acts as a fetal organ capable of expressing cytokines and may play  
role in glycemic control, insulin resistance, and GDM
Human
Fraser et al87 Association between gestational weight gain and later adiposity Human
Note: An accrual of data in recent years has provided compelling evidence supporting the link between the intrauterine programming events and later metabolic outcomes.
Abbreviations: DNA, deoxyribonucleic acid; GRS, genetic risk score; GDM, gestational diabetes mellitus.Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014:7 submit your manuscript | www.dovepress.com
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The childhood obesity epidemic
Childhood malnutrition has taken on a startling new identity 
during the past decade, with caloric excess now more common 
than undernutrition.9–12 The International Association for the 
Study of Obesity and International Obesity Task Force estimate 
that at least 200 million school-age children are overweight 
or obese worldwide.13 Obesity has a long list of comorbidi-
ties, including CVD, T2D,14 hypertension, and sleep apnea, as 
well as emotional/psychological consequences such as social 
stigmatization, discrimination, and low self-esteem.15,16 Indeed, 
the emerging epidemic of pediatric T2D is likely to be a direct 
result of the high prevalence of childhood obesity.17 Together, 
obesity and its sequelae impose an immense burden at a per-
sonal and societal level; thus, childhood obesity represents one 
of the major threats to global health.
Obesity in childhood, particularly in prepubescent chil-
dren, is highly predictive of obesity in adulthood, especially 
when one (or both) parents is obese.18 Childhood body mass 
index (BMI), a strong correlate of adiposity in children, 
predicts premature death from endogenous causes, as do a 
number of other cardiometabolic risk factors (eg, glucose 
tolerance and hypertension).19–23 In a study of American Indian 
children, extreme BMI (the highest quartile compared with 
the lowest quartile) doubled the hazards of premature death.19 
The relationship between childhood obesity and mortality may 
be mediated, in part at least, by dysregulated glucose and by 
hypertension, with abdominal obesity as one of the earliest 
manifestations of metabolic dysregulation. Notably, abdomi-
nal obesity occurring early in childhood (age ,10 years) is 
a very strong risk factor for T2D later in life relative to other 
clinical risk factors, and appears to precede the development 
of glucose intolerance (an important precursor to diabetes) and 
dyslipidemia (a driver of insulin resistance);24 indeed, elevated 
BMI, glucose intolerance, and hypertension, when present in 
childhood, all raise the hazards of premature death.19
Given that childhood obesity is a major determinant of 
cardiometabolic risk later in life, understanding the modifi-
able risk factors for childhood obesity is well justified from 
a public health perspective. Defining early-life risk factors is 
a necessary step for designing interventions that tackle adult 
metabolic disease at its roots.
Metabolic and fetal programming
Pregnancy represents a critical period of development for 
fetal organs involved in maintaining energy homeostasis, 
not least for the pancreas and adipocytes.25 The fetal insulin 
hypothesis describes a scenario where poor fetal nutrition 
induces adaptations that are advantageous to the short-term 
survival of the fetus but have lasting detrimental effects on 
the offspring’s metabolic function that, in later life, cause 
metabolic disease.26 Both under- and overnutrition appear 
to convey similar effects on disease risk, although the pro-
posed mechanisms differ. In undernourished pregnancies, the 
offspring’s metabolism is hypothesized to be optimized for 
extrauterine environments that mirror the intrauterine experi-
ence; accordingly, the obesogenic environments that offspring 
of undernourished pregnancies experience often appear to 
trigger cardiometabolic disease in these individuals. 
In one of the earliest studies documenting the link between 
impaired fetal growth and CVD, investigators sought to 
explain observable differences in CVD risk seen across social 
gradients in England.27 Data recorded in 5,654 boys born in 
1911 in the county of Hertfordshire showed a 3-fold differ-
ence in death rates from ischemic heart disease in adulthood 
between those with the lowest and highest birth weights. Data 
from epidemiologic studies of cohorts born during or soon 
after more recent manmade famines in the People’s Republic 
of China28–30 and Europe31 have provided some of the most 
striking examples of intrauterine malnutrition and cardiometa-
bolic disease susceptibility later in life. Those studies indicate 
that the intrauterine growth of these children is restricted, as 
indicated by low birth weights for gestational age, smaller 
placentas, and shorter stature than are seen in children born 
outside the periods of famine; correspondingly, susceptibility 
to cardiometabolic diseases is generally higher in the former 
than in the latter. One of the most famous examples of such 
is the Dutch winter famine, which occurred toward the end 
of World War II (1944 and 1945) as a consequence of an 
embargo imposed by German forces on food supplies to the 
western parts of the Netherlands. Although the embargo was 
lifted in November of 1944, extreme winter conditions made 
it impossible for food supplies to reach urban areas to the west 
of the country.31 With food supplies dangerously low, ration-
ing was enforced such that daily caloric intake was typically 
around 1,000 calories/day, dropping to 400 calories/day at 
the height of the famine. Thus, the many children born at or 
around this time were severely malnourished during critical 
periods of growth and development. The tragedy of the Dutch 
famine has since been used by epidemiologists to shed light 
on the role of early-life malnutrition on metabolic program-
ming. Those studies have shown that individuals exposed to 
prenatal undernutrition, especially in late gestation, developed 
glucose intolerance as adults.32
Whilst undernourished pregnancies have been the 
model for much of the seminal work on the developmental 
origins of adult disease, a more widespread problem in Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014:7 submit your manuscript | www.dovepress.com
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contemporary societies is that of gestational obesity and fetal 
overnourishment. Offspring of both under- and overnourished 
pregnancies are at higher risk of metabolic disease in adult-
hood compared with moderately nourished offspring; thus, 
the relationship between birth weight and these diseases is 
U-shaped.33–37
Although maternal obesity in pregnancy is strongly 
associated with an adverse metabolic profile in the progeny, 
obesity per se may not cause deleterious programming events 
in the offspring; rather, factors that coalesce with maternal 
obesity, such as hyperglycemia, dyslipidemia, hypertension, 
or inflammation, are likely to be the causal factors.38 High 
intrauterine glucose concentrations, for example, drive the 
pancreatic β-cells to secrete excessive quantities of insulin. 
This process stresses the developing pancreas and, because 
insulin is a growth hormone, stimulates growth, as reflected 
in the heavier birth weights of the offspring.
Extensive epidemiological data demonstrate that the 
offspring of diabetic pregnancies are at much higher risk of 
developing diabetes themselves later in life; in a study of 
911 nondiabetic mothers and 1,436 of their children, we 
showed that the relationship between a mother’s third tri-
mester glucose tolerance (for every standard deviation [SD] 
higher glucose [∼1.3 mmol/L]) equates to a 1.6-fold (95% 
confidence interval 1.3–2.0, P,0.0001) higher risk of dia-
betes in her offspring. This relationship was approximately 
dose dependent and was reflected by a 56 g higher offspring 
birth weight per SD unit maternal glucose (P=0.0002).39 In 
offspring of mothers with manifest diabetes before preg-
nancy, the risk of diabetes was higher still, with roughly half 
of the children born to these women having developed T2D 
themselves by the age of 25 years.39
Elsewhere, in a subcohort of pregnant women with 
and without gestational diabetes mellitus (GDM) from the 
National Collaborative Perinatal Project and their offspring, 
offspring of diabetic mothers had heavier birth weights 
compared with the offspring of mothers without GDM.40 
Furthermore, at age 7 years, the same offspring born to 
GDM mothers had more adipose tissue compared with 
their unexposed counterparts, even after adjusting for birth 
weight, thereby indicating that the relationship between GDM 
exposure and excessive growth of the offspring extends 
beyond the perinatal period. Consequently, the diabetic 
pregnancy is viewed by many to be pivotal in adversely 
impacting the trajectory for T2D later in life, independently 
of genetic factors.41 It may also be that exposure to diabetes 
in utero has wider impacts on health, such that offspring of 
diabetic pregnancies are more predisposed to CVD42 and 
tend to die younger.19 The mechanisms for how intrauterine 
exposures influence the fetus’s cardiometabolic risk trajec-
tories are not well understood in humans, as almost all data 
are observational, but in animals suggest that alterations 
in the transcriptional capacity of genes occur, which may 
involve “epigenetic” processes such as DNA methylation, 
histone modification, chromatin unraveling, and the actions 
of small (micro)ribonucleic acids (RNAs).43
Epigenetics
Unlike germline genetic variation that remains unchanging in 
all cells of the body, epigenetic variation is dynamic and varies 
across tissues in response to a wide spectrum of environmental 
stimuli, including those guiding tissue differentiation dur-
ing growth and development, as well as harmful exposures 
that elicit an adaptive response from cells.   Epigenetic pro-
cesses are hypothesized to modulate the effects of almost 
all environmental exposures on the phenotypes of health 
and disease via transcriptional regulation brought about by, 
for example, methylation of CpG islands in nuclear DNA; 
post-translational modification of histone proteins such as 
acetylation, methylation, phosphorylation, and ubiquitination; 
and RNA interference. Epigenetic modifications are an impor-
tant aspect of biology, as they impart to cells the capacity for 
cellular plasticity and may also act, in response to intrauterine 
triggers, to program cells in preparation for the extrauterine 
environment, essentially priming the genome of the develop-
ing fetus for the world outside the womb. In this way, epige-
netic alterations might potentiate a survival advantage through 
differential regulation of the genes encoding proteins involved 
in energy metabolism and adipogenesis. The conservation 
across generations of cellular memory through epigenetic 
processes has been widely speculated on, with a number of 
intriguing transgenerational observational studies suggesting 
this to be true,44–46 but with no compelling evidence to back 
this up in humans. Thus, the impact of environmental factors 
on cellular programming and the extent to which these are 
conserved across generations represents an intriguing concept 
but requires further investigation.
One study by Heijmans et al47 examined patterns of DNA 
methylation at IGF2, an imprinted locus, in people who 
endured exposure to famine in utero during the Dutch Hunger 
Winter. The study indicated that there are critical periods of 
fetal development when the IGF2 promoter is susceptible to 
hypomethylation. The IGF2 locus was hypomethylated in the 
offspring who were conceived during the famine, whereas 
there were no changes in DNA methylation in the offspring 
exposed to famine in late gestation.47Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014:7 submit your manuscript | www.dovepress.com
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The impact of genomic imprinting (the parental origin of 
specific effects of inherited alleles) on disease has been well 
studied in mouse models and some human studies (see Peters48 
for a review of evidence on genomic imprinting); evidence 
from these studies shows that parent-specific imprinted genes 
have a significant range of effects on biological processes 
extending into adulthood. Until recently, transgenerational 
effects of paternal exposures on subsequent generation(s) were 
rarely considered within the context of the transgenerational 
cycle of disease. Ng et al49 investigated the effects of paternal 
diet on adult rat offspring. The authors observed that glucose 
tolerance was significantly impaired in the female but not the 
male offspring.49 In a subsequent study, the authors sought 
to investigate further the effects of paternal exposure on the 
female offspring. They found that paternal exposure to a high-
fat diet induced impaired glucose tolerance and diminished 
insulin secretion early in life, despite normal adiposity and 
growth rates in the female offspring. The mechanisms that 
underlie these observations appear to involve impaired β-cell 
replication and epigenetic modification at Il13ra2.49 Another 
murine study showed that in utero caloric restriction is associ-
ated with loci-specific hypomethylation in the male germline 
at differentially methylated regions that can partially survive 
reprogramming processes in early embryo development, with 
altered gene expression at discrete sites.
Epigenetic programming and gene–environment inter-
actions appear to be important factors to consider when 
unraveling the dynamic (epi)genetic architecture of complex 
diseases across lineages. Although it seems highly plausible 
that transgenerational epigenetic processes may affect disease 
predisposition, it is difficult to exclude cultural and societal 
factors serving concurrently, or alternatively, as a vehicle 
for disease transmission across generations. The integration 
of nonbiological (socioeconomic, cultural, and lifestyle) 
and biological (genetic and epigenetic) information into 
disease prediction models is an increasingly important area 
of research that may have relevance when considering early 
interventions against adult cardiometabolic diseases.50
Genetics
A major challenge in examining the impact of environmental 
components in pregnancy and early life on later disease risk 
is that these relationships are often confounded by genetic 
factors, which are also shared by the mother and her offspring. 
Most complex metabolic traits are probably the consequence 
of interactions between genetic and environmental (especially 
lifestyle) factors. Studying such interactions is challenging, 
owing to the relatively small magnitude of the anticipated 
interaction effects and the difficulty in accurately and pre-
cisely quantifying lifestyle behaviors. Early attempts to 
address this challenge have involved the use of discordant 
monozygotic twins to disentangle the effects of the intrauter-
ine milieu from those primarily attributable to the offspring’s 
genotype.51
There is increasing information regarding the genetic 
basis of T2D and obesity, two metabolic disorders long since 
determined to be heritable.52 Genome-wide association stud-
ies have been the mainstay of population genetics research 
for much of the past decade and have been used to uncover a 
plethora of novel loci associated with complex traits. To date, 
more than 50 established genomic regions harboring variants 
associated with T2D have been discovered and confirmed.53 
However, heritability studies that seek to partition the genetic 
from nongenetic sources of variance in a trait indicate that 
whilst T2D has a large genetic component, the role of envi-
ronmental risk factors is likely to be larger still.51
The role of genetic factors in gestational diabetes is less 
well studied. However, in a recent analysis of the Diabetes 
Prevention Program (DPP), a randomized controlled trial 
(RCT) of more than 3,000 adults randomized to receive a pro-
gram of intensive lifestyle modification, metformin treatment, 
or placebo control intervention, we examined the association 
of 34 established T2D loci with history of GDM, response to 
intervention, and indices of β-cell function.54 We modeled the 
genetic loci in aggregate using a genetic risk score. Women 
with a history of GDM had diminished β-cell function, and 
the genetic risk score was associated with GDM history but 
not with response to the DPP interventions. These data suggest 
that the genetic defects that lead to T2D are likely to overlap 
with those involved in the pathogenesis of GDM.
Owing to the role of fetal growth and development in T2D, 
genes that encode these phenotypes may be plausible candi-
dates for T2D. This hypothesis has been tested in a number of 
candidate gene and genome-wide association studies analyses, 
with several birth weight-associated loci also being implicated 
in T2D and other metabolic traits:55–57 eg, common variants at 
the ADCY5 and CDKAL1 with T2D, fasting glucose, and fast-
ing insulin concentrations, with the allele associated with lower 
birth weight also being associated with high diabetes risk55–57 
and levels of glucose and insulin.58–60 Similarly, the birth 
weight-associated allele at ADRB1 has been associated with 
adult blood pressure.61 Moreover, when 47 established T2D-
associated variants were tested in unison for association with 
birth weight, the diabetes risk-raising alleles were statistically 
associated with lower birth weight than would be expected by 
chance.62 Although these data support a causal relationship Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014:7 submit your manuscript | www.dovepress.com
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between fetal growth and later risk of cardiometabolic disease, 
some genes will have pleiotropic effects on growth, develop-
ment, and adult disease, which may confound associations 
between birth weight and later disease.
As indicated, interactions between genetic variants and 
environmental risk factors may also determine the risk of 
obesity and diabetes in childhood and adult life. One such 
locus is proximal to the FTO gene, which harbors the strongest 
single nucleotide variant (rs9960939) for polygenic obesity 
in children and adults.63–65 FTO may play a role in appetite 
regulation and energy balance.66–69 For example, in a study of 
Scottish school children, Cecil et al66 reported a higher ratio of 
energy intake and energy expenditure in carriers of the minor 
(A) allele compared with those carrying the lower-risk T allele; 
interestingly, energy expenditure, albeit insufficient to offset 
energy intake, was higher than in the T allele carriers, a finding 
that was subsequently confirmed in adults.70 As well, Wardle 
et al71 showed that the T allele was associated with lower food 
intake, suggesting that the T allele promotes sensitivity to 
satiety. Elsewhere, Church et al68 reported an interaction of the 
rs9960939 variant with age on children’s weight gain trajecto-
ries, and found that the A allele was associated with lower BMI 
in infancy but a higher BMI in later childhood. Furthermore, 
adiposity rebound occurred earlier in developmental age in 
children carrying the minor A allele compared with noncar-
riers.72 This observation may be important, as early onset of 
adiposity rebound has been shown to predict later overweight 
and obesity.73,74 Hence, it is possible that FTO influences 
developmental processes in distinct ways throughout infancy 
and later childhood, although underlying mechanisms remain 
unknown. A prospective population-based study of children 
residing in the Brazilian Amazon examined the effects of the 
FTO rs9939609 minor risk allele on weight gain in childhood 
of predominantly mixed race/ethnicity and observed that those 
associations were modified by vitamin D levels, which have 
been shown to be negatively correlated with measures of child 
adiposity.75 Common FTO variants also appear to be associated 
with rate of childhood weight gain, which may be augmented 
in children with lower levels of vitamin D.76
The role of the placenta
Maternal nutrition and placental insufficiency77 are especially 
relevant in fetal growth and development, as these factors 
have a direct effect on determining the amount and quality of 
nutrient supply to the embryo and fetus. A mother’s lifestyle 
behaviors in pregnancy regulate energy input and output 
(ie, diet/nutrition and physical activity) and may position the 
fetus’s energy set point to affect obesity predisposition later 
in life. The placenta not only acts as a buffer to regulate the 
transfer of small molecules such as fatty acids to the fetal 
compartment but also acts as a sink for excess fetal glucose. 
However, when the placenta’s capacity to do so is exceeded, 
and the fetus is exposed to high glucose and protein levels, 
fetal macrosomia can ensue.78 Together, maternal behaviors 
and the ability of the placenta to function appropriately deter-
mine the availability of necessary nutrients to the fetus and 
also the ability to maintain a homeostatic environment and to 
avoid exposure to excessive levels of glucose and proteins, 
some of which are harmful to the fetus.
The placenta is a fetal organ capable of expressing cytok-
ines that may play a role in glycemic control, insulin resistance, 
and GDM.79 Placenta tissues, for example, secrete leptin during 
hyperglycemia.80 Leptin and insulin are hormones that play 
a coordinated role in sympathetic nerve activity38 and in the 
programming of hypothalamic circuitry involved in appetite 
regulation.81 Additionally, placenta may undergo morphologi-
cal adaptations in response to intrauterine exposures, such as 
levels of glycemia,82 which may result in long-term deleterious 
effects on metabolic programming. For example, high placenta 
weight, particularly in lower birth weight infants, is associated 
with elevated blood pressure in adulthood.83
Obesity and weight gain trajectories
In 2009, the Institute of Medicine (IOM) established new 
guidelines for limiting maternal weight gain during pregnancy 
by trimester based on the mother’s prepregnancy BMI. With 
the release of these new recommendations, the IOM also high-
lighted the need for more research investigating the impact 
of these new guidelines on pediatric health outcomes.84 In 
response to this solicitation, the association of weight gain in 
pregnancy and childhood overweight/obesity at age 2–5 years 
was assessed.85 The study showed that children of mothers 
who exceeded the recommended weight gain were larger at 
birth and had a greater odds of overweight/obesity in child-
hood, after adjusting for potential confounders, compared with 
the offspring of mothers whose weight gain was within the 
recommended range; the study also showed that prepregnancy 
BMI may modify the association of gestational weight gain 
and infant risk. Elsewhere, relationships between maternal 
prepregnancy BMI, gestational weight gain, and maternal and 
child health outcomes at birth were assessed in 33,973 Chinese 
mother–infant dyads.86 The study showed that mothers who 
were overweight or obese prior to pregnancy, compared with 
those who were normal weight, were at higher risk of GDM 
despite gestational weight gain being within the range defined 
as adequate by the IOM.Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014:7 submit your manuscript | www.dovepress.com
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In a subsample of the Avon Longitudinal Study of Parents 
and Children, a prospective cohort study of pregnant women 
and their offspring, investigators examined the impact of 
gestational weight gain by trimesters and found a positive 
association between gestational weight gain in early preg-
nancy and infant adiposity at age 9 years; the magnitude of 
this relationship was even greater in mothers who gained more 
than 500 g/wk. The same relationship persisted in midpreg-
nancy only in mothers who gained more than 500 g/wk.87
Eriksson et al88 found correlations between growth 
trajectories in childhood and coronary heart disease. 
Most affected were children who experienced compensatory 
“catch-up growth” or accelerated weight gain in childhood. 
These children exhibited a 5-fold elevated risk of death from 
coronary heart disease.
High-risk populations
Indigenous populations such as Alaskan Natives, American 
Indians, Inuits, and Australian Aborigines are perceived by 
many to be genetically prone to obesity and diabetes, largely 
because of their high degree of susceptibility to these diseases 
following abrupt unhealthful shifts in lifestyle over the past 
few decades, yet the specific risk loci are largely unknown. 
Analysis of data from Pima Indians residing in southern 
Arizona has contributed to a number of landmark studies 
focused on intrauterine exposure to diabetes and later T2D 
risk. Those studies have shown, for example, that Pima Indian 
children tend to be overweight and hyperinsulinemic.89 In 
this population, a diabetic intrauterine environment conveys 
increased risk for childhood hyperglycemia and systolic 
hypertension, independently of adiposity.90 As adults, 
Pimas born to diabetic pregnancies are at far higher risk of 
developing early onset T2D due to lower insulin secretory 
rates.91 With hyperglycemia and overt T2D occurring at even 
younger ages (ie, within reproductive age) than in most other 
populations, the intrauterine risks associated with gestational 
diabetes are readily transmitted from one generation to the 
next, thus perpetuating the transgenerational cycle of T2D 
and obesity within these populations (Figure 1).
Although mainland indigenous minority populations are 
often at high risk of obesity and diabetes, indigenous island 
populations appear even more so, with seven out of the 
Adult cardiometabolic
disease
Maternal lifestyle factors
Intrauterine
exposures
Genetic propensity
Epigenetic
modifications
Overweight/obesity
Dyslipidemia
Early-onset T2D
GDM/hyperglycemia
Excessive weight gain
Obesity
Stress
Poor diet/nutrition
Low levels of physical activity
Overweight/obesity
Type 2 diabetes
Cardiovascular disease
Childhood metabolic
dysregulation
Figure 1 The vicious cycle of cardiometabolic disease. 
Notes: Risk trajectories of cardiometabolic disease may be shaped by maternal lifestyle factors that influence the intrauterine milieu. When these obesogenic signals 
effectively elicit adverse epigenetic programming events in the developing fetus, then cardiometabolic dysregulation may ensue in early childhood and progress more rapidly 
toward overt disease outcomes in later adulthood.
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top ten countries/territories with the highest prevalence of 
age-adjusted diabetes worldwide being those that reside on 
small islands.92 Populations of small islands are especially 
susceptible to this phenomenon, probably as a result of strong 
genetic founder effects that interact with the recent transition 
from subsistence farming to Westernized lifestyles, where 
island food supplies now often depend heavily on imported 
foods that are energy dense and nutritionally deficient. This 
process is thought to have created a “mismatch” between the 
fetus’s epigenome, which has been programmed to expect a 
thrifty extrauterine environment, and the extrauterine reality 
of caloric excess.93
Evidence from RCTs
While substantial observational evidence appears to support 
hypotheses that cardiometabolic risk trajectories are estab-
lished as a result of events in early life, far fewer supportive 
data are available from RCTs. To date, there is relatively limited 
information examining whether interventions to prevent and/or 
reduce harmful intrauterine exposures are effective in improv-
ing health outcomes in both the mother and child.94 Large-
scale, consortium-wide pregnancy RCTs as well as smaller 
regional RCTs have been implemented in the past several 
years to investigate the impact of lifestyle interventions during 
pregnancy and early life. However, intervention strategies and 
the IOM recommendations84 are careful to focus on weight gain 
in pregnancy rather than weight loss, as safety considerations 
surrounding weight loss in pregnancy have yet to be adequately 
addressed.95 The Treatment of Obese Pregnant Women (TOP) 
study was an RCT in Denmark that recruited obese (BMI $30 
kg/m2) pregnant women from 2009 to 2012.96 Four hundred and 
twenty-five women were randomly allocated to one of three 
treatment groups: 1) physical activity and diet, 2) physical 
activity only, or 3) no intervention, standard care. The authors 
of the study concluded that physical activity measured using a 
pedometer, regardless of treatment group, resulted in a reduc-
tion in gestational weight gain in these women. As with similar 
pregnancy intervention trials, the relatively small sample size 
may have yielded insufficient statistical power to detect dif-
ferences in infant health outcomes. Currently, larger RCTs are 
being implemented to assess lifestyle effects on pregnancy 
outcomes. The LIMIT study,97 a more recent RCT in Aus-
tralia, is designed to investigate whether limiting gestational 
weight gain in overweight and obese pregnant women through 
comprehensive dietary and lifestyle recommendations will 
reduce the number of infants who are excessive birth weight 
and associated maternal and infant morbidities. Similarly, in 
2012, the US National Institutes of Health (NIH) established 
the Lifestyle Interventions for Expectant Moms (LIFE-Moms) 
Consortium consisting of seven sites across the US.98 The aim 
of the consortium is to identify effective lifestyle interven-
tions that favorably impact gestational weight gain and other 
measures of cardiometabolic health in the mother and infant. 
An additional ongoing RCT from the UK (UPBEAT99) is 
recruiting 1,546 obese pregnant women, who are subsequently 
randomized to receive a program of lifestyle intervention or 
control. The primary outcomes of the trial are GDM and large 
for gestational age infants. The findings of these studies are 
expected to resolve some of the ambiguity surrounding preg-
nancy and early lifestyle interventions and their effectiveness 
as public health strategies for improving maternal, neonatal, 
and infant cardiometabolic health.
Future clinical and public health 
implications based on current 
evidence
The majority of today’s guidelines and intervention strategies 
against obesity-related diseases often do not account for the 
possibility that cardiometabolic risk trajectories may be set 
in the very early stages of life, when system-wide injuries 
affecting energy homeostasis begin to occur. However, 
guidelines for improving cardiometabolic health in the US 
population have been issued by the NIH Heart, Lung, and 
Blood Institute,84 which focus on screening of childhood 
obesity and limiting weight gain in pregnancy, respectively. 
Targeting children within the population who are at great-
est risk for cardiometabolic complications in adulthood 
requires being able to accurately identify those with adverse 
lipid profiles, excess body fat, glucose dysregulation, high 
blood pressure, and other indicators. The National Heart, 
Lung, and Blood Institute calls for universal lipid screening 
between the ages of 9 and 11 years;84 however, the feasibility 
and economic implications of these recommendations are 
not known. In addition, lifestyle interventions in childhood 
may be perceived as extreme, and general screening may be 
unable to detect underlying pathophysiological mechanisms 
that may not fully manifest until later in life.
Although lifestyle interventions (physical activity and diet) 
are important public health strategies against obesity-related 
diseases because they beneficially affect multiple systems in 
the body, this approach alone is unlikely to curb the global 
obesity epidemic. Optimizing detection and preventative strat-
egies will entail exploration in early life, from preconception 
to early childhood, to identify novel biomarkers that indicate 
aberrant metabolic programming events early on. More tar-
geted strategies for reducing T2D and CVD may require risk Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014:7 submit your manuscript | www.dovepress.com
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stratification approaches based on intermediate risk factors 
such as molecular (eg, micro-RNA and [epi]genetic), anthro-
pometric, and biological (eg, microbiota) markers, rather than 
overt phenotypes, like diabetes status, coronary heart disease, 
stroke, or metabolic syndrome, that are detectable in early stages 
of development. For example, altered or impaired epigenetic 
dynamics in preadipocyte differentiation may lead to perma-
nent morphological and functional changes in fat tissue100 – a 
major player in the endocrine system orchestrating a cascade 
of transcription factors, including the peroxisome proliferator-
activated receptor γ involved in signaling networks of glucose 
regulation and energy balance.101 Furthermore, assessing the 
validity of epigenetic inheritance, in other words the transmis-
sion of epigenetic regulatory features acquired as an adaptive 
response to an environmental signal affecting one generation to 
subsequent generation(s) that has not been exposed directly to 
the environmental “trigger(s)”, will have major implications in 
forecasting the societal burden of chronic disease. In this way, 
investigating the primordial defects associated with the cluster 
of traits defining metabolic syndrome may provide important 
insight into potential targets for future preventative strategies.
Conclusion
Maximizing strategies for preventing or modifying exces-
sive morbidity and mortality associated with complex dis-
eases requires a more complete understanding of its earliest 
modifiable risk factors and consideration of this knowledge 
in public health recommendations. Epidemiological studies 
have already made major contributions to our understand-
ing of how adverse exposures in utero and during childhood 
impact disease risk trajectories, which now require experi-
mental validation. Numerous clinical trials are now underway 
or completed to assess the effects of intervening during 
pregnancy and childhood to improve prognosis in those 
considered at high risk, usually determined on the basis of 
the mother’s early pregnancy weight or glucose tolerance. As 
the body of evidence from clinical trials grows, the extent to 
which the hypotheses set forth through observational studies 
are valid will become clear, and solid evidence-based guide-
lines designed to prevent obesity, T2D, and CVD, which 
account for early-life exposures, will likely take form.
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